About Us
Meet the team behind Nanophage Technologies
We are a passionate team of scientists, innovators, and problem-solvers dedicated to advancing diagnostics through cutting-edge science. Get to know the people driving our mission forward!
Paul Smith, Chief Executive Officer
Paul brings decades of international science-based product commercialization experience to Nanophage. A senior business leader in Australia, then New Zealand as managing director of Merck (MSD), Paul has managed revenue budgets of >$250m and led the New Zealand business to triple sales whilst reducing costs. He has built and led New Zealand teams through many changes including; a spin out, political advocacy, and go to market model. Paul began his career in the UK as a research organic chemist before moving into sales and marketing with a global German chemical company covering the UK and Ireland. Following his MBA, he joined a French management consultancy in portfolio management, resource allocation, and launch strategy for most of the top 10 Pharma companies across the globe. Paul brings a passion for commercial success of innovations to make positive changes for patients and build thriving New Zealand businesses. He has been a member of several boards across Australia and New Zealand and completed his Institute of Director’s course. You will find Paul outdoors at the weekends trying to keep up running with his family who are on horseback.
Cathy Davenport, Research & Commercial Development Scientist
Cathy is a co-inventor of the nanorod technology and a PhD candidate at Massey University, where she is exploring how nanorods can be applied in diagnostics and vaccine development. Alongside her research, she has gained valuable experience in commercializing scientific discoveries through the KiwiNet Emerging Innovator program and an internship at Massey Ventures. Cathy’s passion for translating research into real-world clinical solutions stems from her firsthand experience as an EMT working on the ambulance, where she recognized the need for better medical innovations to improve patient care.
Jennifer Tu, R&D Scientist
Jennifer is an R&D Scientist and Lab Manager. She works on modifying nanorods, including antibody conjugation, dye labeling, and attaching other molecules for diagnostic use. With her background in protein biochemistry and chemical conjugation, she focuses on improving molecular interactions and boosting the sensitivity of targeted applications. She also manages lab operations to keep things running smoothly and efficiently. Outside of work, Jennifer is a professional cat sitter and loves finding good food spots.
Ruby Roach, R&D Scientist
Ruby is both an R&D Scientist and Science Communicator at Nanophage Technologies, where she desings and engineers biological nanorods and spearheads science communication efforts. She holds a PhD in Biochemistry from Massey University, with expertise in protein-nucleic acid interactions, molecular cloning, and structural biology. Ruby also has a strong background in governence, start-up mentorship, and science outreach. Outside of work, she keeps herself busy with learning te reo Māori and playing tennis.
Aseel Mohammad, Biotechnologist
Aseel is a PhD candidate at Massey University and a Biotechnologist at Nanophage Technologies. With expertise in recombinant protein expression, cloning, and mammalian cell biology, Aseel supports the team with her practical knowledge. She focuses on research and solutions that contribute directly to the company’s goals. Outside of the lab, Aseel is passionate about fitness and enjoys reading.
Our team makes detection molecules brighter with our Nanophage scaffolds
Join the Team
We’d love to hear from you.